Search Results 151-160 of 14919 for Tamoxifen

1. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

2. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

3. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

4. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

5. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

6. Publications - Malvika H. Solanki, M.B.B.S., Ph.D. - Mayo Clinic

   ... tamoxifen +/- fluoxymesterone. Breast Cancer Res. 2025 Mar 19; 27 (1):40. View PubMed; Bhatt AA, Harper LK, Anderson S, Solanki MH, Ataya DK. Cystic Breast ...

7. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   ... tamoxifen; Developing a new drug to replace tamoxifen for people with low CYP2D6 enzyme activity; Developing a new drug for women with resistance to aromatase ...

8. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

9. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

   First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

10. Medical Research & Education - Mayo Clinic News Network

    Women's Wellness: Do hot flashes indicate heart disease? Dana Sparks. February 1, 2018. New international practice guidelines for tamoxifen treatment based on ...